Revised SPC: Tygacil (tigecycline) 50mg powder for solution for infusion

Recommendation has been added regarding the need for monitoring of coagulation parameters, including blood fibrinogen, prior to and during tigecycline treatment; as well as a related update to frequency of existing side effect hypofibrinogenaemia from not known to rare.

Source:

electronic Medicines compendium